Yüklüyor......

Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale

Clinical and epidemiological studies of anticancer therapies increasingly seek to identify predictive biomarkers to obtain insights into variation in treatment benefit. For time to event endpoints, a predictive biomarker is typically assessed using the interaction between the biomarker and treatment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Contemp Clin Trials
Asıl Yazarlar: Satagopan, Jaya M., Iasonos, Alexia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568905/
https://ncbi.nlm.nih.gov/pubmed/28254404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.02.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!